Cancer News Headlines

The Food and Drug Administration said Friday it approved the pill Xtandi for men with advanced prostate cancer that has returned or spread despite major medical intervention.

Pfizer Inc. will work with privately held biotechnology company VLST Corp. on a potential immune therapy for cancer.

Onyx Pharmaceuticals Inc. and Bayer HealthCare said Thursday that Bayer has filed for U.S. marketing approval of a gastrointestinal cancer drug the companies are developing.

Shares of Geron Corp. climbed Thursday after a Stifel Nicolaus analyst said the company should report a series of positive results from clinical trials of two cancer drugs over the coming months.

Bristol-Myers Squibb Co. is recalling more than 31,000 units of a chemotherapy drug after discovering one vial was overfilled, putting patients at risk of an overdose.

COPENHAGEN (Reuters) - Genmab has agreed a deal that could be worth over $1.1 billion with a unit of Johnson & Johnson for the rights to a cancer agent, giving the U.S. company a 10.7 percent equity stake in the Danish biotech group. Genmab said on Thursday that J&J; unit Janssen Biotech Inc would obtain global license rights …

(Reuters) - Exelixis Inc said U.S. regulators have dropped an advisory panel discussion on the marketing application for its experimental drug to treat a rare form of thyroid cancer, sending its shares up 6 percent after market. "It's a positive. That means the committee did not have a big issue or concern on this drug." …

Exelixis Inc. said Wednesday that a Food and Drug Administration advisory panel no longer plans to discuss its thyroid cancer drug cabozantinib at a meeting in November.

NEW YORK (Reuters Health) - When given additional information, prostate cancer patients are less likely to remain undecided about which treatment they want and are less likely to want their prostates removed, in a new study. Perhaps not surprisingly, Dutch researchers found that just 2 percent of patients remained undecided …

Shares of ArQule Inc. plunged Wednesday after the company said one of its partners has stopped enrolling patients in a clinical trial of its cancer drug tivantinib.

FIRST PERSON | An injectable form of Herceptin may be available to patients with HER2 positive breast cancer in the near future. Injectable Herceptin has many benefits over the traditionally IV-administered version. The main benefit is patient comfort and experience. Administering Herceptin subcutaneously instead of through …

(Reuters) - Biotechnology company ArQule Inc said Japan's Kyowa Hakko Kirin Co, which holds development rights to an ArQule cancer drug in parts of Asia, suspended patient enrollment in a late-stage trial to treat lung cancer. Shares of Woburn, Massachusetts-based ArQule fell 28 percent to a more than 9-month low of $4.81 …

PHILADELPHIA (Reuters) - Former Senator Arlen Specter, a major political figure in Pennsylvania and Washington for more than four decades, is once again fighting cancer, his office said Tuesday. A statement issued by Specter's office did not specify the type of cancer he is fighting, and a spokesman declined to elaborate. …

Novartis AG and Incyte Corp. said Tuesday that European Union regulators approved their blood cancer drug Jakavi.

Former U.S. Sen. Arlen Specter of Pennsylvania says he is fighting cancer again.

Renowned classical pianist Van Cliburn has been diagnosed with advanced bone cancer and is resting comfortably at his Texas home, his publicist said Monday.

COPENHAGEN (Reuters) - Danish pharmaceutical group Lundbeck said on Tuesday it had received approval from Health Canada for its cancer treatment Treanda which is used to treat two common types of cancer including lymphocytic leukemia. Lundbeck said the move would substantially strengthen the group's growth outlook, but …

ZURICH, Aug 28 (Reuters - Swiss drugmaker Novartis AG has received approval from the European Commission for Jakavi, a drug for myelofibrosis, a rare blood cancer, that was licensed from Incyte. The drug was already recommended for approval in April by a key panel for Europe's health regulator. Novartis said in a statement …

Men undergoing prostate cancer treatment commonly suffer side effects such as the growth of breast tissue or breast pain, but the breast-cancer drug tamoxifen may reduce the risk of these effects, a new review says.

Lance Armstrong, branded a drug cheat and banned from cycling by the US Anti-Doping Agency, can still count on support from the cancer community, the head of the Union for International Cancer Control said Monday.

NEW YORK (Reuters Health) - How frequently older women use aspirin and other pain relievers has nothing to do with their chance of developing breast cancer, a large new study suggests. Previous research has painted a cloudy picture, with some studies indicating that women who regularly take so-called nonsteroidal anti-inflammatory …

Drugmakers ImmunoGen Inc. and Roche said Monday that a promising breast cancer treatment extended patients' lives in a late-stage clinical trial.

NEW YORK (Reuters Health) - Among women who have been treated for breast cancer, heavier women are more likely to have their disease come back and more likely to die of cancer, according to a new study. That could be because certain hormones that are linked to body weight may also fuel tumor growth in the most common form …